PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.95%
Negative revenue growth while BIDU stands at 15.48%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-10.97%
Negative gross profit growth while BIDU is at 64.16%. Joel Greenblatt would examine cost competitiveness or demand decline.
-19.98%
Negative EBIT growth while BIDU is at 933.87%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-19.98%
Negative operating income growth while BIDU is at 933.87%. Joel Greenblatt would press for urgent turnaround measures.
1.80%
Net income growth under 50% of BIDU's 8629.27%. Michael Burry would suspect the firm is falling well behind a key competitor.
2.00%
EPS growth under 50% of BIDU's 8500.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
4.08%
Diluted EPS growth under 50% of BIDU's 8500.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.68%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.76%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
22.20%
OCF growth under 50% of BIDU's 272.74%. Michael Burry might suspect questionable revenue recognition or rising costs.
57.95%
FCF growth under 50% of BIDU's 344.01%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
424.42%
10Y revenue/share CAGR under 50% of BIDU's 1276.52%. Michael Burry would suspect a lasting competitive disadvantage.
116.48%
5Y revenue/share CAGR above 1.5x BIDU's 60.57%. David Dodd would look for consistent product or market expansions fueling outperformance.
49.52%
3Y revenue/share CAGR above 1.5x BIDU's 25.82%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
526.76%
OCF/share CAGR of 526.76% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
100.74%
OCF/share CAGR of 100.74% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
91.95%
3Y OCF/share CAGR above 1.5x BIDU's 10.20%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
253.21%
Net income/share CAGR at 75-90% of BIDU's 332.63%. Bill Ackman would press for strategic moves to boost long-term earnings.
77.39%
Positive 5Y CAGR while BIDU is negative. John Neff might view this as a strong mid-term relative advantage.
100.54%
Positive short-term CAGR while BIDU is negative. John Neff would see a clear advantage in near-term profit trajectory.
376.74%
Below 50% of BIDU's 2620.84%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
85.85%
Below 50% of BIDU's 179.62%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
41.98%
3Y equity/share CAGR at 50-75% of BIDU's 68.21%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.02%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-8.32%
Inventory is declining while BIDU stands at 51.44%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.86%
Similar asset growth to BIDU's 1.82%. Walter Schloss finds parallel expansions or investment rates.
2.50%
BV/share growth above 1.5x BIDU's 1.16%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-4.94%
We’re deleveraging while BIDU stands at 3.19%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
0.81%
R&D dropping or stable vs. BIDU's 8.91%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-12.11%
We cut SG&A while BIDU invests at 14.67%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.